世界の慢性特発性便秘(CIC)治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV00261)
◆英語タイトル:Global Chronic Idiopathic Constipation (CIC) Drugs Market Insights and Forecast to 2026
◆商品コード:QYR20NV00261
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:114
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは慢性特発性便秘(CIC)治療薬の世界市場について調査・分析した資料です。種類別(ルビプロストン、リナクロチド、その他)の市場規模、用途別(病院・診療所、外来外科センター、介護センター、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別慢性特発性便秘(CIC)治療薬の競争状況、市場シェア
・世界の慢性特発性便秘(CIC)治療薬市場:種類別市場規模 2015年-2020年(ルビプロストン、リナクロチド、その他)
・世界の慢性特発性便秘(CIC)治療薬市場:種類別市場規模予測 2021年-2026年(ルビプロストン、リナクロチド、その他)
・世界の慢性特発性便秘(CIC)治療薬市場:用途別市場規模 2015年-2020年(病院・診療所、外来外科センター、介護センター、その他)
・世界の慢性特発性便秘(CIC)治療薬市場:用途別市場規模予測 2021年-2026年(病院・診療所、外来外科センター、介護センター、その他)
・北米の慢性特発性便秘(CIC)治療薬市場分析:米国、カナダ
・ヨーロッパの慢性特発性便秘(CIC)治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの慢性特発性便秘(CIC)治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の慢性特発性便秘(CIC)治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの慢性特発性便秘(CIC)治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Actavis、Chugai Pharmaceutical、Ferring International Center、Synergy Pharmaceuticals、Pfizer、GlaxoSmithKline、Roche Holding、Sanofi、Bayer、Salix Pharmaceuticals、Sucampo Pharmaceuticals、Ironwood Pharmaceuticals、Progenics Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of difficult, infrequent, or incomplete bowel movements.

Market Analysis and Insights: Global Chronic Idiopathic Constipation (CIC) Drugs Market
The global Chronic Idiopathic Constipation (CIC) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Chronic Idiopathic Constipation (CIC) Drugs Scope and Market Size
Chronic Idiopathic Constipation (CIC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Idiopathic Constipation (CIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Chronic Idiopathic Constipation (CIC) Drugs market is segmented into
Lubiprostone
Linaclotide
Others

Segment by Application, the Chronic Idiopathic Constipation (CIC) Drugs market is segmented into
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others

Regional and Country-level Analysis
The Chronic Idiopathic Constipation (CIC) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Idiopathic Constipation (CIC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chronic Idiopathic Constipation (CIC) Drugs Market Share Analysis
Chronic Idiopathic Constipation (CIC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Idiopathic Constipation (CIC) Drugs business, the date to enter into the Chronic Idiopathic Constipation (CIC) Drugs market, Chronic Idiopathic Constipation (CIC) Drugs product introduction, recent developments, etc.

The major vendors covered:
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals

【レポートの目次】

1 Study Coverage
1.1 Chronic Idiopathic Constipation (CIC) Drugs Product Introduction
1.2 Market Segments
1.3 Key Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type
1.4.2 Lubiprostone
1.4.3 Linaclotide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application
1.5.2 Hospitals & Clinics
1.5.3 Ambulatory Surgical Centres
1.5.4 Long Term Care Centres
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue 2015-2026
2.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2015-2026
2.2 Global Chronic Idiopathic Constipation (CIC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Chronic Idiopathic Constipation (CIC) Drugs Competitor Landscape by Players
3.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers
3.1.1 Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers
3.2.1 Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation (CIC) Drugs Revenue in 2019
3.2.5 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Manufacturers
3.4 Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type (2015-2020)
4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020)
4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2015-2020)
4.1.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application (2015-2020)
5.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020)
5.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2015-2020)
5.1.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2015-2020)
5.2 Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Chronic Idiopathic Constipation (CIC) Drugs by Country
6.1.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
6.1.2 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
6.3 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Chronic Idiopathic Constipation (CIC) Drugs by Country
7.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
7.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
7.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs by Region
8.1.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region
8.1.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs by Country
9.1.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
9.1.2 Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
9.3 Central & South America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs by Country
10.1.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country
10.1.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Actavis
11.1.1 Actavis Corporation Information
11.1.2 Actavis Description and Business Overview
11.1.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.1.5 Actavis Related Developments
11.2 Chugai Pharmaceutical
11.2.1 Chugai Pharmaceutical Corporation Information
11.2.2 Chugai Pharmaceutical Description and Business Overview
11.2.3 Chugai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.2.5 Chugai Pharmaceutical Related Developments
11.3 Ferring International Center
11.3.1 Ferring International Center Corporation Information
11.3.2 Ferring International Center Description and Business Overview
11.3.3 Ferring International Center Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.3.5 Ferring International Center Related Developments
11.4 Synergy Pharmaceuticals
11.4.1 Synergy Pharmaceuticals Corporation Information
11.4.2 Synergy Pharmaceuticals Description and Business Overview
11.4.3 Synergy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.4.5 Synergy Pharmaceuticals Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Roche Holding
11.7.1 Roche Holding Corporation Information
11.7.2 Roche Holding Description and Business Overview
11.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.7.5 Roche Holding Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.8.5 Sanofi Related Developments
11.9 Bayer
11.9.1 Bayer Corporation Information
11.9.2 Bayer Description and Business Overview
11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.9.5 Bayer Related Developments
11.10 Salix Pharmaceuticals
11.10.1 Salix Pharmaceuticals Corporation Information
11.10.2 Salix Pharmaceuticals Description and Business Overview
11.10.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.10.5 Salix Pharmaceuticals Related Developments
11.1 Actavis
11.1.1 Actavis Corporation Information
11.1.2 Actavis Description and Business Overview
11.1.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered
11.1.5 Actavis Related Developments
11.12 Ironwood Pharmaceuticals
11.12.1 Ironwood Pharmaceuticals Corporation Information
11.12.2 Ironwood Pharmaceuticals Description and Business Overview
11.12.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Ironwood Pharmaceuticals Products Offered
11.12.5 Ironwood Pharmaceuticals Related Developments
11.13 Progenics Pharmaceuticals
11.13.1 Progenics Pharmaceuticals Corporation Information
11.13.2 Progenics Pharmaceuticals Description and Business Overview
11.13.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Progenics Pharmaceuticals Products Offered
11.13.5 Progenics Pharmaceuticals Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chronic Idiopathic Constipation (CIC) Drugs Market Estimates and Projections by Region
12.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Idiopathic Constipation (CIC) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Idiopathic Constipation (CIC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Actavis、Chugai Pharmaceutical、Ferring International Center、Synergy Pharmaceuticals、Pfizer、GlaxoSmithKline、Roche Holding、Sanofi、Bayer、Salix Pharmaceuticals、Sucampo Pharmaceuticals、Ironwood Pharmaceuticals、Progenics Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の慢性特発性便秘(CIC)治療薬市場2026:インサイト・予測(Global Chronic Idiopathic Constipation (CIC) Drugs Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。